Viome
Data driven. Evidence based. The future of health is here.
Seattle, United States · Founded 2016 · $218.5M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2C
- Website
- viome.com
- Total Funding
- $218.5M
- Last Round
- $25.0M Series DJan 2024
- Rounds
- 5
About
Viome is a direct-to-consumer health company that uses AI-powered RNA sequencing to analyze the gut microbiome and deliver personalized nutrition recommendations, supplement formulas, and probiotics. Its at-home tests cover gut, oral, and full-body health, translating complex biological data into actionable food and supplement guidance. The platform has analyzed over 600,000 samples.
Summary
Viome is a Healthcare company based in Seattle, United States, founded in 2016. It has raised $218.5M in total across 5 rounds, most recently a $25.0M Series D round in Jan 2024. Investors include Khosla Ventures, Bold Capital Partners and Marc Benioff.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe